Williams Christopher Ty
DNP Program, Vanderbilt University School of Nursing, 461 21st Avenue South, Nashville, TN 37240, USA.
Nurs Clin North Am. 2016 Mar;51(1):1-11. doi: 10.1016/j.cnur.2015.10.007. Epub 2016 Jan 13.
In this article, the processing of investigational and new drug applications is described and the standard and expedited review processes are examined. The efforts of the US Food and Drug Administration to ensure greater agency transparency and fiscal responsibility and intensify oversight during the drug development and approval process are reviewed. Often attributed to a decrease in the number of uninsured adults, both the increase in prescription drug sales and the high costs associated with bringing a new drug to market highlight the necessity for a streamlined and cost-effective process to deliver these drugs safely and effectively.
本文描述了研究性新药申请和新药申请的处理过程,并审视了标准审评流程和加速审评流程。回顾了美国食品药品监督管理局为确保更高的机构透明度和财政责任以及在药物研发和审批过程中加强监管所做的努力。处方药销售额的增长以及将一种新药推向市场所涉及的高昂成本,通常被认为是未参保成年人数量减少所致,这凸显了建立一个精简且具成本效益的流程以安全有效地交付这些药物的必要性。